Piramal, Ci-Co Healthcare partner on F-18 florbetaben in S. Korea

11/21/2013 | AuntMinnie.com (free registration)

Piramal Imaging and Ci-Co Healthcare have established a strategic partnership and exclusive licensing deal to commercialize PET amyloid imaging agent F-18 florbetaben in South Korea. Ci-Co Healthcare will seek regulatory authorization to commercialize florbetaben, which will be manufactured and supplied by radiopharmacy network operator DuChemBio.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health